CompoAtlas

Surge 2.0 Pineapple

On sale on the US market (according to the DSLD)

Advanced Nutrition Systems, food supplement from the US market

Surge 2.0 Pineapple (Advanced Nutrition Systems), a food supplement au code-barres 814995020086, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

If this product were sold in France

No point flagged by the rules we apply.

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
Advanced Nutrition Systems
Barcode
814995020086
Form
Powder
One serving
21.88 g
Servings
up to 1 serving per day
Other ingredients (in English, as written)
Citric Acid, Natural Flavors, Calcium Silicate, Sucralose, Silicon Dioxide, Acesulfame Potassium, Yellow Color
Ingredient (as written, in English)CategoryPer serving
CaloriesOther40 Calorie(s)
Total CarbohydratesCarbohydrate10 Gram(s)
SodiumMineral5 mg
Surge 2.0 BlendBlend20,645 mg
Amino Recovery BlendBlend10,701 mg
MaltodextrinCarbohydratenot stated
Waxy MaizeCarbohydratenot stated
L-GlutamineAmino acidnot stated
L-LeucineAmino acidnot stated
L-HistidineAmino acidnot stated
L-Ornithine AKGOther substancenot stated
L-IsoleucineAmino acidnot stated
L-ValineAmino acidnot stated
Amla extract (Phyllanthus emblica)Plantnot stated
Nitrovascular BlendBlend5,030 mg
CarnoSynAmino acidnot stated
L-Arginine AKGOther substancenot stated
L-Citrulline DL MalateOther substancenot stated
L-ArginineAmino acidnot stated
L-Arginine DL MalateOther substancenot stated
L-NorvalineAmino acidnot stated
Agmatine SulfateOther substancenot stated
ATP Volumizing BlendBlend3,010 mg
Kre-AlkalynOther substancenot stated
Creatine MagnaPowerOther substancenot stated
Creatine MonohydrateOther substancenot stated
Creatine HClOther substancenot stated
Extreme Energy/Focus BlendBlend1,904 mg
TaurineOther substancenot stated
Caffeine AnhydrousOther substance295 mg
N-Acetyl L-TyrosineOther substancenot stated
Synephrine HClOther substancenot stated
Kola Nut powderPlantnot stated
RutaecarpineOther substancenot stated
Di-Caffeine MalateOther substancenot stated
Mucuna pruriens extract (Mucuna pruriens)Plantnot stated
Phosphatidyl Serine powderFatnot stated
Huperzine AOther substancenot stated

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • L-Glutamine
    Read the warning, when it applies and the studies cited

    L-Glutamine

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

  • Amla extract
    Read the warning, when it applies and the studies cited

    Amla - Phyllanthus Emblica

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Applies to products providing more than 3 grams of amla, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Condition of application: Amlapitta, Digestive tonic.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Laxative.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).

    Sources cited by Health Canada (3)
    • CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
    • Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.

    Contraindications

    Condition of application: Laxative.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Known adverse reactions

    Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.

    When using this product you may experience a laxative effect.

    Health Canada monograph dated 28 March 2025

  • Taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : Advanced Nutrition Systems

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Surge 2.0 Pineapple (Advanced Nutrition Systems): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/814995020086-surge-2-0-pineapple-advanced-nutrition-systems, updated 31 August 2018.

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line